Eli Lilly said on Wednesday that a clinical trial had shown that patients taking its weight-loss drug Zepbound (tirzepatide) ...

Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia ...

Nearly half of participants in a weight loss program who initiated an antiobesity medication and who consumed alcohol at ...

The table below is a review of notable updates that occurred in November 2024 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

As anti-obesity medications gain popularity, a new concern has also gained traction among researchers: increased food waste. A self-administered online survey sponsored by Ohio State found that 25% of ...

GLP-1 receptor agonist use is associated with benefits in a number of different disease and may help treat patients with lupus nephritis.

Neurotone AI, pioneer in aural rehabilitation, and creator of Lace AI Pro, today announced it has entered into a definitive agreement to acquire Amptify, a leading digital hearing healthcare platform ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...

Southeastern Printing, a premier South Florida omni-channel marketing and brand management company, announces its achievement ...

After losing and regaining the same 20-plus pounds more times than she could count, Anita Blanchard concluded that diets ...

Brand companies who own GLP-1 products have been pushing the Food and Drug Administration (FDA) to limit their compounding. On August 28, 2024, ...

GLP-1s have been heralded for their ability to suppress appetite but did you know that GLP-1 is a natural hormone you can stimulate without injections.